CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)
HKD 0.41
(0.0%)
HKD 0.41
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 228.38 Million | 363.65 Million | 423.57 Million | 530.95 Million | 379.14 Million | 230.69 Million |
| Net Income | 17.25 Million | 204.86 Million | 238.23 Million | 119.12 Million | 217.43 Million | 421.22 Million |
| Depreciation & Amortization | 96.12 Million | 230.91 Million | 246.88 Million | 220.36 Million | 204.41 Million | 138.29 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 69.57 Million | -121.12 Million | -141.59 Million | 156.73 Million | -2.4 Million | -268.76 Million |
| Other non-cash items | 45.43 Million | 49 Million | 80.04 Million | 34.72 Million | -40.29 Million | -60.06 Million |
| Investing Cash Flow | -81.14 Million | -22.11 Million | -257.88 Million | -457.31 Million | -253.91 Million | -373.88 Million |
| Investments in PPE | -291.82 Million | -216.96 Million | -217.24 Million | -379.83 Million | -197.77 Million | -287.79 Million |
| Acquisitions | 33.2 Million | 24.66 Million | 1.13 Million | -3.58 Million | -149.63 Million | -85.92 Million |
| Investment purchases | -28.35 Million | -42.9 Million | -44.78 Million | -81.84 Million | -69.21 Million | -186.85 Million |
| Sales/Maturities of investments | 75.29 Million | 223.21 Million | 43.65 Million | 85.43 Million | 218.84 Million | 77.93 Million |
| Other Investing Activities | 130.53 Million | -10.13 Million | -40.63 Million | -77.47 Million | -56.14 Million | 108.75 Million |
| Financing Cash Flow | -178.96 Million | -515.34 Million | -220.08 Million | 168.74 Million | -192.21 Million | -97.75 Million |
| Debt repayment | -7.55 Million | -1.4 Billion | -1.1 Billion | -3.89 Billion | -924 Million | -115.39 Million |
| Dividends payments | -76.88 Million | -96.11 Million | -96.11 Million | -96.11 Million | -96.11 Million | -96.11 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -320.89 Million | 987.77 Million | 976.03 Million | 4.16 Billion | 827.89 Million | 113.75 Million |
| Accounts receivables | 51.43 Million | -189.53 Million | -117.36 Million | 251.16 Million | 94.89 Million | -20.16 Million |
| Accounts payables | -36.46 Million | 164.01 Million | -40.47 Million | 92.22 Million | -97.41 Million | -45.35 Million |
| Inventory | 54.6 Million | -95.59 Million | 16.23 Million | -186.65 Million | 116 Thousand | -203.24 Million |
| Other working capital | -36.46 Million | - | - | - | - | - |
| Cash at beginning of period | 691.93 Million | 890.8 Million | 958.99 Million | 696.5 Million | 773.37 Million | 1.03 Billion |
| Cash at end of period | 664.32 Million | 691.93 Million | 890.8 Million | 958.99 Million | 696.5 Million | 773.37 Million |
| Capital Expenditure | -291.82 Million | -216.96 Million | -217.24 Million | -379.83 Million | -197.77 Million | -287.79 Million |
| Effect of forex changes on cash | 4.11 Million | -25.06 Million | -13.8 Million | 20.1 Million | -9.88 Million | -23.44 Million |
| Net cash flow / Change in cash | -27.61 Million | -198.86 Million | -68.19 Million | 262.49 Million | -76.87 Million | -264.39 Million |
| Free Cash Flow | -63.44 Million | 146.69 Million | 206.32 Million | 151.11 Million | 181.37 Million | -57.1 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1 Million | -19.66 Million | 17.25 Million | 36.91 Million | 204.86 Million | 66.84 Million |
| Depreciation & Amortization | 81.82 Million | 47.78 Million | 96.12 Million | 48.33 Million | 230.91 Million | 49.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 106.03 Million | 69.57 Million | - | -121.12 Million | -285.13 Million |
| Other non-cash items | 62.58 Million | 215.32 Million | 45.43 Million | 91.92 Million | 49 Million | -1.75 Million |
| Investing Cash Flow | -95.76 Million | -64.77 Million | -81.14 Million | -16.37 Million | -22.11 Million | 35.28 Million |
| Investments in PPE | - | -287.67 Million | -291.82 Million | - | -216.96 Million | -952 Thousand |
| Acquisitions | - | - | 33.2 Million | - | 24.66 Million | 24.66 Million |
| Investment purchases | - | - | -28.35 Million | - | -42.9 Million | -239.53 Million |
| Sales/Maturities of investments | - | - | 75.29 Million | - | 223.21 Million | 223.21 Million |
| Other Investing Activities | -95.76 Million | 236.09 Million | 130.53 Million | -16.37 Million | -10.13 Million | 27.89 Million |
| Financing Cash Flow | -155.44 Million | 86.26 Million | -178.96 Million | -265.22 Million | -515.34 Million | -190.7 Million |
| Debt repayment | - | - | -7.55 Million | - | -1.4 Billion | - |
| Dividends payments | - | - | -76.88 Million | -76.88 Million | -96.11 Million | -96.11 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -155.44 Million | -212.72 Million | -320.89 Million | -188.33 Million | 987.77 Million | -330.87 Million |
| Accounts receivables | - | 51.43 Million | 51.43 Million | - | -189.53 Million | -189.53 Million |
| Accounts payables | - | - | -36.46 Million | - | 164.01 Million | - |
| Inventory | - | 54.6 Million | 54.6 Million | - | -95.59 Million | -95.59 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 664.32 Million | 493.39 Million | 691.93 Million | 691.93 Million | 890.8 Million | 847.08 Million |
| Cash at end of period | 549.2 Million | 664.32 Million | 664.32 Million | 493.39 Million | 691.93 Million | 691.93 Million |
| Capital Expenditure | - | -287.67 Million | -291.82 Million | - | -216.96 Million | -952 Thousand |
| Effect of forex changes on cash | -9.31 Million | 1.55 Million | 4.11 Million | 2.56 Million | -25.06 Million | -14.92 Million |
| Net cash flow / Change in cash | -115.12 Million | 170.92 Million | -27.61 Million | -198.53 Million | -198.86 Million | -155.15 Million |
| Free Cash Flow | 145.4 Million | -139.79 Million | -63.44 Million | 80.49 Million | 146.69 Million | 14.23 Million |
1950
CEINSYSTECH
3052
7765
NEELKANTH
CBWTF